Sustainable and Therapeutic Chemical Biology
Research in my group takes a multidisciplinary approach at the interface between chemistry and biology. We use synthetic molecules to systematically investigate the functions of genes, cells, and biochemical pathways in living systems.
Currently, we have five key focus areas. We work on understanding complex biological systems, for example by studying enzyme affinity for various unnatural substrates, which is relevant for the development of targeted prodrugs. We engage in hit optimization to develop new and effective treatments with the synthesis and screening of molecular compounds. In addition, we investigate strategies for improving drug delivery to the brain, such as barrier shuttle mechanisms, and linker designs that enable brain-selective drug release to reduce site effects.
Furthermore, we work with antibody-based treatments, where our efforts include antibody modification to improve therapeutic properties and the development of strategies that enable antibody-based approaches to treat brain diseases. Our fifth current area is sustainable chemistry, where we are developing an indican-based, light-driven blue denim dying as a sustainable alternative for the textile industry.